Equities
  • Price (EUR)99.74
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-16.61%
  • Beta1.2120
Data delayed at least 15 minutes, as of Apr 23 2019 07:13 BST.
More ▼

Profile data is unavailable for this security.

About the company

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.

  • Revenue in USD (TTM)213.52bn
  • Net income in USD-371.00m
  • Incorporated1994
  • Employees78.00k
  • Location
    McKesson Corp1 Post StSAN FRANCISCO 94104-5203United StatesUSA
  • Phone+1 (415) 983-8300
  • Fax+1 (302) 636-5454
  • Websitehttp://www.mckesson.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MCK:NYQ since
announced
Transaction
value
Medical Specialties Distributors LLCDeal completed25 Apr 201825 Apr 2018Deal completed-22.14%800.00m
Data delayed at least 15 minutes, as of Apr 23 2019 18:48 BST.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.